BusinessPhoto: Mint MarketsSudarshan Pharma Shares Rise 30% in 2026, Profit Booking Seen Post Q2 Results
Sudarshan Pharma Industries shares surged 30% in 2026 but faced selling pressure after hitting a 52-week high of ₹42.79. The stock dropped to ₹34.65 intraday due to profit-booking following Q2FY26 results that met market expectations. Experts say the rally was partly driven by the company’s mainboard listing after moving from the BSE SME platform. The Q2 report showed strong year-on-year growth and net profit gains.
Mint Markets·


